Skip to content
Facebook-f
Twitter
Instagram
Youtube
MalignantNoMore
  • Treatments
  • Trial Search
  • About
Menu
  • Treatments
  • Trial Search
  • About
Search
Search
MalignantNoMore MalignantNoMore MalignantNoMore

MalignantNoMore

  • Treatments
  • Trial Search
  • About
  • Treatments
  • Trial Search
  • About

Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice

Notes from the article:
Mistletoe therapy worked synergistically with Chemotherapy and Radiation
The authors concluded that Mistletoe Therapy should be a treatment option

Continue reading
Mistletoe

Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe

Notes from the study:
Those receiving the Mistletoe Therapy took twice as long to show sign of disease recurrence
Those receiving Mistletoe Therapy lived twice as long as well

Continue reading
Mistletoe

Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma (METT)

In 12 locations in South Korea for those experiencing Recurrence or Progression

Continue reading
Metformin

A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging

Located in New York, NY, eligibility is Open

Continue reading
Ketogenic Metformin

Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM

Based out of McGill University in Canada for Patients Newly Diagnosed

Continue reading
Metformin

Metformin influences progression in diabetic glioblastoma patients

Notes from the study:
Metformin usage by diabetic patients was correlated with a higher percentage of desired outcomes

Continue reading
Metformin

Metformin as Potential Therapy for High-Grade Glioma

Notes from the article:
Low toxic and usually well-tolerated, Metformin appears to increase the effectiveness of both chemotherapy and radiation

Continue reading
Metformin

Melatonin’s Antineoplastic Potential Against Glioblastoma

Notes from the article:
The authors of this study call the lab experiments involving Melatonin “remarkable”
The authors also find it to be a promising agent in the fight against cancer

Continue reading
Melatonin

Role and Therapeutic Potential of Melatonin in the Central Nervous System and Cancers

Notes from the article:
Chemoprotective and an effective cancer-fighting agent, the authors call for more cancer studies involving Melatonin

Continue reading
Melatonin

Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone

Notes from the study:
Melatonin supplementation led to both longer survival time and disease-free progression

Continue reading
Melatonin
  • Previous
  • 1
  • 2
  • 3
  • 4
  • Next
Search
MalignantNoMore

We’re looking to grow the number of contributors here at MalignantNoMore; so, if you’d like to get involved in anyway, please contact us at:

contact@malignantnomore.org

Links
  • About MalignantNoMore
  • Treatments
  • Trial Search
  • Contact
Menu
  • About MalignantNoMore
  • Treatments
  • Trial Search
  • Contact
Recent Posts
February 21, 2021

Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems

February 21, 2021

Focus on the Use of Resveratrol as an Adjuvant in Glioblastoma Therapy

Stay in the know

Sign up below to receive MNM news delivered straight to you

Facebook-f
Instagram
Twitter
Youtube
  • Privacy Policy
  • GDPR Cookie Policy
  • GDPR Privacy Policy
Menu
  • Privacy Policy
  • GDPR Cookie Policy
  • GDPR Privacy Policy

Cookie Notice

We use cookies as some are necessary to run the site and others provide information about who visits us. If you'd like to opt-out of any non-necessary cookies, you can do by clicking the Cookie Settings button to the right. Learn More

Ok Cookie Settings
Cookies are small text files that can be used by websites to make a website more efficient. The law states that we can store cookies on a device if they are strictly necessary for the operation of this site. For all other types of cookies we need permission. This site uses different types of cookies including some cookies are placed by third party services.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
    Name Domain Purpose Expiry Type
    wpl_user_preference www.malignantnomore.org WP GDPR Cookie Consent Preferences 1 year HTTP
    YSC youtube.com YouTube session cookie. Session HTTP
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
    Name Domain Purpose Expiry Type
    GPS youtube.com Google advertising domain Session HTTP
    VISITOR_INFO1_LIVE youtube.com YouTube cookie. Session HTTP
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
    Name Domain Purpose Expiry Type
    _ga malignantnomore.org Google Universal Analytics long-time unique user tracking identifier. 2 years HTTP
    _gid malignantnomore.org Google Universal Analytics short-time unique user tracking identifier. 1 day HTTP
    _gat_gtag_UA_176823838_1 malignantnomore.org --- Session ---
    IDE doubleclick.net Google advertising cookie used for user tracking and ad targeting purposes. 1 day HTTP
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Powered by GDPR Cookie Consent Plugin